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Abstract
This paper extends a method of estimating population average treatment effects to
settings with noncompliance. Simulations show the proposed compliance-adjusted es-
timator performs better than its unadjusted counterpart when compliance is relatively
low and can be predicted by observed covariates. We apply the proposed estimator to
measure the effect of Medicaid coverage on health care use for a target population of
adults who may benefit from expansions to the Medicaid program. We draw random-
ized control trial data from a large-scale health insurance experiment in which a small
subset of those randomly selected to receive Medicaid benefits actually enrolled.
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1 Introduction
Randomized control trials (RCTs) are the gold standard for estimating the causal effect of
a treatment. An RCT may give an unbiased estimates of sample average treatment effects,
but external validity is an issue when the individuals in the RCT are unrepresentative of the
actual population of interest. For example, the participants in an RCT in which individuals
volunteer to sign up for health insurance may be in poorer health at baseline than the overall
population. External validity is particularly relevant to policymakers who want to know how
the treatment effect would generalize to the broader population.
A new research frontier for causal inference focuses on developing methods for extrapolat-
ing RCT results to a population (e.g., Imai et al., 2008). Existing approaches to this problem
are based in settings where there is full compliance with treatment. However, noncompliance
is a prevalent issue in RCTs and occurs when individuals who are assigned to the treatment
group do not comply with the treatment. For individuals assigned to control, we are unable
to observe who would have complied had they been assigned treatment. Noncompliance
biases the intention–to–treat (ITT) estimate of the effect of treatment assignment toward
zero.
We propose a method to estimate the complier–average causal effects for the target pop-
ulation from RCT data with noncompliance, and refer to this estimator as the Population
Average Treatment Effect on Treated Compliers (PATT-C). PATT-C involves the expecta-
tion of the response of RCT compliers, conditional on their covariates, where the expectation
is taken over the distribution of covariates for population members receiving treatment. Our
estimation strategy differs from reweighting methods that use propensity scores to adjust
the RCT data. In Stuart et al. (2011), for example, a propensity score model is used to
predict participation in the RCT, given pretreatment covariates common to both the RCT
and population data. Individuals in the RCT and population are then weighted according
to the inverse of the estimated propensity score. Similarly, Hartman et al. (2015) propose
a method of reweighting the responses of individuals in an RCT according to the covariate
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distribution of the population.
Our approach for estimating PATT-C differs from previous approaches because we only
need the potential outcomes for RCT compliers and we cannot observe who in the control
group would have complied had they been assigned treatment. We propose an alternative
approach of modeling compliance in the RCT and using the compliance model to predict
the likely compliers in the RCT control group.1 Assuming that the response surface is
the same for compliers in the RCT and population members who received treatment, we
then predict the response surface for all RCT compliers and use the predicted values from
the response surface model to estimate the potential outcomes of population members who
received treatment, given their covariates.
When estimating the average causal effect for compliers from an RCT, researchers typ-
ically scale the estimated ITT effect by the compliance rate, assuming that there is only
single crossover from treatment to control.2 When extrapolating RCT results to a popu-
lation, one might simply reweight the ITT effect according to the covariate distribution of
the population and then divide by the proportion of treated compliers in the population in
order to yield a population average effect of treatment on treated compliers. However, we
do not observe the population compliance rate. Moreover, the population compliance rate
is likely to differ across subgroups based on pretreatment covariates. By explicitly modeling
compliance, this approach allows researchers to decompose population estimates by covariate
group, which is useful for policymakers in evaluating the efficacy of policy interventions for
subgroups of interest in a population.
We apply the proposed estimator to measure the effect of Medicaid coverage on health
care use for a target population of adults who may benefit from government-backed expan-
1Reweighting methods typically leverage exchangeability of potential outcomes between the covariate-
adjusted treated and controls in the RCT. In our approach, the potential outcomes between the complier
treated and complier controls are not exchangeable by design, since we need to assume we know the compli-
ance model.
2Alternative approaches include estimating sharp bounds to the ITT effect in the presence of noncom-
pliance (Balke and Pearl, 1997; Imai et al., 2013), adjustment for treatment noncompliance using principal
stratification (Frangakis and Rubin, 2002; Frumento et al., 2012), and maximum-likelihood and Bayesian
inferential methods (Yau and Little, 2001).
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sions to the Medicaid program. We are particularly interested in measuring the effect of
Medicaid on emergency room (ER) use because it is the main delivery system through which
the uninsured receive health care. The uninsured could potentially receive higher quality
health care through primary care visits. An important policy question is whether Medicaid
expansions will decrease ER utilization and increase primary care visits by the previously
uninsured. We draw RCT data from a large-scale health insurance experiment, in which less
than half of those randomly selected to receive Medicaid benefits actually enrolled. We find
substantial differences between sample and population estimates in terms of race, education,
and health status subgroups.
The paper proceeds as follows: Section 2 presents the proposed estimator and the neces-
sary assumptions for its identifiability; Section 3 describes the estimation procedure; Section
4 reports the estimator’s performance in simulations; Section 5 uses the estimator to identify
the effect of extending Medicaid coverage to the low–income adult population in the U.S;
Section 6 discusses the results and offers direction for future research.
2 Estimator
We are interested in using the outcomes from an RCT to estimate complier–average causal
effects for a target population. Compliance with treatment in the population is not assigned
at random, but rather may depend on unobserved variables, confounding the effect of treat-
ment received on the outcome of interest. RCTs are needed to isolate the effect of treatment
received.
Ideally, we would take the results of an RCT and reweight the sample such that the
reweighted covariates match the those in the population. In practice, one rarely knows
the true covariate distribution in the target population. Instead, we consider data from a
nonrandomized, observational study in which participants are representative of the target
population. The proposed estimator combines RCT and observational data to overcome
3
these issues.
2.1 Assumptions
Let Yisd be the potential outcome for individual i in group s and treatment received d. Let
Si denote the sample assignment, where s = 0 is the population and s = 1 is the RCT. Ti
indicates treatment assignment and Di indicates whether treatment was actually received.
Treatment is assigned at random in the RCT, so we observe both Di and Ti when Si = 1.
For compliers in the RCT, Di = Ti.
The absence of Ti in the subscript of the potential outcomes notation implicitly assumes
the exclusion restriction, which ensures treatment assignment affects potential outcomes only
through the treatment received. In particular, Yi11 = Yi10 for noncompliers in the RCT.
Let Wi be individual i’s observable pretreatment covariates that are related to the sample
selection mechanism for membership in the RCT, treatment assignment in the population,
and complier status. Let Ci be an indicator for individual i’s compliance with treatment,
which is only observable for individuals in the RCT treatment group.
In the population, we suppose that treatment is made available to individuals based on
their covariates Wi. Individuals with Ti = 0 do not receive treatment, while those with
Ti = 1 may decide whether or not to accept treatment. For individuals in the population,
we only observe Di — not Ti.
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Assumption 1. Consistency under parallel studies:
Yi0d = Yi1d ∀ i , d = {0, 1}.
Assumption (1) requires that each individual i has the same response to treatment, whether
i is in the RCT or not. Compliance status Ci is not a factor in this assumption because we
3We frame Assumptions (3) and (4) in terms of Ci and Ti in order to distinguish among the population
controls who should have received treatment (i.e., individuals with Ti = 1 and Di = 0) from noncompliers
assigned to control (i.e., individuals with Ti = 0 and Di = 0).
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assume that compliance is conditionally independent of sample and treatment assignment
for all individuals with covariates Wi.
Assumption 2. Conditional independence of compliance and sample and treatment assign-
ment:
Ci ⊥ Si, Ti | Wi, 0 < P(Ci = 1 | Wi) < 1.
Assumption (2) implies that P (Ci = 1|Si = 1, Ti = 1,Wi) = P (Ci = 1|Si = 1, Ti = 0,Wi),
which is useful when predicting the probability of compliance as a function of covariates Wi
in the first step of the estimation procedure. Together, Assumptions (1) and (2) ensure that
potential outcomes do not differ based on sample assignment or receipt of treatment.
Assumption 3. Strong ignorability of sample assignment for treated:
(Yi01, Yi11) ⊥ Si | (Wi, Ti = 1, Ci = 1), 0 < P(Si = 1 | Wi, Ti = 1, Ci = 1) < 1.
Assumption (3) ensures the potential outcomes for treatment are independent of sample
assignment for individuals with the same covariates Wi and assignment to treatment.
4 We
make a similar assumption for the potential outcomes under control.
Assumption 4. Strong ignorability of sample assignment for controls:
(Yi00, Yi10) ⊥ Si | (Wi, Ti = 1, Ci = 1), 0 < P(Si = 1 | Wi, Ti = 1, Ci = 1) < 1.
Restrictive exclusion criteria in RCTs can result in a sample covariate distribution that
differs substantially from the population covariate distribution, thereby reducing the exter-
nal validity of RCTs (Rothwell, 2005). High rates of exclusion also poses a threat to strong
ignorability assumptions if exclusion increases the likelihood that there are unobserved differ-
ences between the RCT and target population that are correlated with potential outcomes.
4Throughout, we assume individuals are sampled randomly from an infinite population.
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For example, the RCT described in Section 5 required enrolled participants to recertify their
eligibility status every six months during the study period. The exclusion of participants who
failed to recertify because their household income exceeded a given cutoff threatens strong
ignorability if the factors that contributed to the failure to recertify are correlated with un-
observables that are also correlated with potential outcomes. The placebo tests described
in Section 5.3.1 are designed to detect bias arising from violations of the strong ignorability
assumptions.5
Assumption 5. No interference between individuals:
Yisd ⊥ Dj, ∀ j 6= i.
Interference undermines the framework because it creates more than two potential out-
comes per participant, depending on other individuals’ treatment received (Rubin, 1990).
Figure 1 shows Assumptions (1) – (5) in a directed acyclic graph. Ti may only depend on
Ci through Wi, and the potential outcomes (Yis0, Yis1) may only depend on Si through Wi.
Confounding arcs represent potential back-door paths that contain unobserved variables.
The confounding arc between Ci and Yisd, for example, represents unmeasurable factors that
influence both individuals’ compliance status and their response to treatment received. The
existence of back-door paths from Di to Yisd imply that the average causal effect of Di on
Yisd cannot be identified by just conditioning on Wi; i.e. we cannot ignore Si and Ci.
From the internal validity standpoint, the role of Wi is critical: if any relevant observed
covariates are not controlled, then there is a back-door pathway from Ti back to Wi and into
Yisd.
6
5Note that Assumptions (3) and (4) also imply strong ignorability of sample assignment for treated
and control noncompliers since Assumption (2) states that compliance is also independent of sample and
treatment assignment, conditional on Wi. However, we are interested only on modeling the response surfaces
for compliers.
6We use the same Wi across all identifying assumptions, which implicitly assumes that the observable
covariates that determine sample selection also determine population treatment assignment and complier
status.
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Figure 1: Causal diagram indicating assumptions needed to estimate the PATT-C. Solid uni-
directional arrows represent causal links between quantities and dashed bidirectional arrows
represent confounding arcs.
We include an additional assumption made by Angrist et al. (1996) to identify the average
causal effect for compliers. Assumption (6) ensures that noncompliance is one-sided; i.e.,
individuals assigned to control are not allowed to receive treatment. It explicitly rules out
the existence of individuals who always receive treatment (i.e, never-takers) and those who
receive the opposite of their treatment assignment (i.e., defiers).
Assumption 6. One-sided noncompliance:
P(Di | Ti = 0) = 0, ∀ i.
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2.2 PATT-C
PATT-C is interpreted as the average treatment effect estimated on those in the population
who would receive treatment if they were in the RCT and assigned to the treatment. This
interpretation follows directly from Assumptions (1) and (2), which ensure that potential
outcomes do not differ based on sample assignment or receipt of treatment. It is written as
follows:
τPATT-C = E (Yi01 − Yi00 | Si = 0, Di = 1) . (1)
The following theorem relates the treatment effect in the RCT to the treatment effect in the
population.
Theorem 1. Under Assumptions (1) – (6),
τPATT-C = E01 [E (Yi11 | Si = 1, Di = 1,Wi)]− E01 [E (Yi10 | Si = 1, Ti = 0, Ci = 1,Wi)] (2)
where E01 [E(· | . . . ,Wi)] denotes the expectation with respect to the distribution of Wi for
population members who received treatment.
Proof. We separate the expectation linearly into two terms and consider each individually.
E (Yi01 | Si = 0, Di = 1) = E (Yi11 | Si = 0, Di = 1) by Assumption (1)
= E (Yi11 | Si = 0, Ti = 1, Ci = 1) by Assumption (6)
= E01 [E (Yi11 | Si = 0, Ti = 1, Ci = 1,Wi)]
= E01 [E (Yi11 | Si = 1, Ti = 1, Ci = 1,Wi)] by Assumption (3)
= E01 [E (Yi11 | Si = 1, Di = 1,Wi)]
Intuitively, conditioning on Wi makes sample selection ignorable under Assumption (3).
This is the critical connector between the third and fourth lines of the first expectation
derivation.
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E (Yi00 | Si = 0, Di = 1) = E (Yi10 | Si = 0, Di = 1) by Assumption (1)
= E (Yi10 | Si = 0, Ti = 1, Ci = 1) by Assumption (6)
= E01 [E (Yi10 | Si = 1, Ti = 1, Ci = 1,Wi)] by Assumption (4)
= E01 [E (Yi10 | Si = 1, Ti = 0, Ci = 1,Wi)] by Assumption (2)
The last line follows because Assumption (2) allows us to use RCT controls who would
have complied had they been assigned to treatment. Finally, the result follows by plugging
these two expressions into Eq. (1).
3 Estimation procedure
There are two challenges in turning Theorem (1) into an estimator of τPATT-C in practice.
First, we must estimate the inner expectation over potential outcomes of compliers in the
RCT. In the empirical example, we use an ensemble of algorithms (van der Laan et al., 2007)
to estimate the response surface for compliers in the RCT, given their covariates. Thus, the
first term in the expression for τPATT-C is estimated by the weighted average of points on the
response surface, evaluated for each treated population member’s potential outcome under
treatment. The second term is estimated by the weighted average of points on the response
surface, evaluated for each treated population member’s potential outcome under control.
The second challenge is that we cannot observe which individuals are included in the
estimation of the second term. In the RCT control group, Ci is unobservable, as they always
receive no treatment (Di = 0). We must estimate the second term of Eq. (2) by predicting
who in the control group would be a complier had they been assigned to treatment. Explicitly
modeling compliance allows us to decompose PATT-C estimates by subgroup according to
covariates common to both RCT and observational datasets. This approach also accounts
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for settings where the compliance rate differs between the sample and population, as well as
across subgroups.
The procedure for estimating τPATT-C using Theorem (1) is as follows:
S.1 Using the group assigned to treatment in the RCT (Si = 1, Ti = 1), train a model
(or an ensemble of models) to predict the probability of compliance as a function of
covariates Wi.
S.2 Using the model from S.1, predict who in the RCT assigned to control would have com-
plied to treatment had they been assigned to the treatment group. We dichotomize
the predicted values based on an “optimal” cut-point that minimizes the Euclidean
distance between the ROC curve and the (0,1) corner of the ROC plane. This method,
which is commonly used in the epidemiology literature (Perkins Neil and Schister-
man Enrique, 2006), minimizes misclassification error by finding the cut-point closest
to where the true positive rate (i.e., the proportion of sample compliers correctly iden-
tified) is 1 and the inverse of the true negative rate (i.e., the share of noncompliers
correctly identified) is 0. We locate a prediction threshold of 45% that balances the
true positive and true negative rates at about 70% each.
S.3 For the observed compliers assigned to treatment and predicted compliers assigned to
control, train a model to predict the response using Wi and Di, which gives E(Yi1d |
Si = 1, Di = d,Wi) for d ∈ {0, 1}.
S.4 For all individuals who received treatment in the population (Si = 0, Di = 1), estimate
their potential outcomes using the model from S.3, which gives Yi1d for d ∈ {0, 1}. The
mean counterfactual Yi11 minus the mean counterfactual Yi10 is the estimate of τPATT-C.
Assumptions (3) and (4) are particularly important for estimating τPATT-C: the success
of the proposed estimator hinges on the assumption that the response surface is the same
for compliers in the RCT and target population. If this does not hold, then the potential
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outcomes Yi10 and Yi11 for target population individuals cannot be estimated using the model
from S.3. Section 5.3 discusses whether the strong ignorability assumptions are plausible in
the empirical application.
3.1 Modeling assumptions
In addition to the identification assumptions, we require additional modeling assumptions
for the estimation procedure. As pointed out in Section 2.1, we require that Wi is complete
because if any relevant elements of Wi are not controlled, then there is a backdoor pathway
from Ti back to Wi and into Yisd. Additionally, we assume that the compliance model is
accurate in predicting compliance in the training sample of RCT participants assigned to
treatment and also generalizable to RCT participants assigned to control (S.1 and S.2).
Section 3.2 below describes the method of evaluating the generalizability of the compliance
model.
3.2 Ensemble method
In the empirical application, we use the Super learner weighted ensemble method (van der
Laan et al., 2007) for the estimation steps S.1 and S.3. Super learner combines algorithms
with a convex combination of weights based on minimizing cross-validated error, and typi-
cally outperforms single algorithms selected by cross-validation (Polley and Van Der Laan,
2010).
We choose a variety of candidate algorithms to construct the ensemble, with a prefer-
ence towards algorithms that tend to perform well in supervised classification tasks. We
also have a preference for algorithms that have a built-in variable selection property.7 We
select three types of candidate algorithms: additive regression models (Buja et al., 1989);
7The idea is that we input the same Wi and each candidate algorithm selects the most important
covariates for predicting compliance status or potential outcomes. A potential concern when predicting
potential outcomes is that the algorithm might shrink the treatment received predictor to zero, which would
result in no difference between counterfactual potential outcomes.
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gradient boosted regression (Friedman, 2001); L1 or L2-regularized linear models (i.e., Lasso
or ridge regression, respectively) (Tibshirani et al., 2012); and ensembles of decision trees
(i.e., random forests) (Breiman, 2001). L1-regularized linear models are important for the
application due to their variable selection properties: Lasso is particularly attractive because
it tends to shrink all but one of the coefficients of correlated covariates to zero.
4 Simulations
We conduct a simulation study comparing the performance of the PATT-C estimator against
its unadjusted analogue, which we refer to as the Population Average Treatment Effect on
the Treated (PATT):
τPATT = E (Yi01 − Yi00 | Si = 0, Di = 1) . (3)
Eq. (3) identifies the population-average causal effect of taking up treatment, adjusted ac-
cording to the covariate distribution of population members who received treatment. We
estimate the response curve for all RCT participants, conditional on their covariates and
actual treatment received. Identical to S.4 in the estimation procedure for PATT-C, we use
the response model to estimate the outcomes of population members who received treatment
given their covariates, which are then used to estimate Eq. (3). Like the PATT-C estimator,
the PATT estimator crucially relies on the assumption that the response surface is the same
for RCT participants and population members who received treatment.
We compare the population estimators against the sample Complier Average Causal
Effect (CACE) (Imbens and Rubin, 1997), which is commonly referred to the Local Average
Treatment Effect in the econometrics literature (Imbens and Angrist, 1994; Angrist et al.,
1996). In the context of program evaluation, it is a more relevant treatment effect of interest
than the ITT effect because only RCT participants who received treatment would have their
outcomes affected by treatment in the presence of a nonnegative treatment effect.
CACE is defined as the average causal effect of treatment received restricted to sample
12
compliers:
τCACE = E (Yi11 − Yi10 | Si = 1, Ci = 1) . (4)
In other words, CACE is the treatment effect for RCT participants who would comply
regardless of treatment assignment. However, we are unable to observe the compliance
status of RCT participants assigned to control because we do not know if they would have
complied if they had been assigned to treatment. A generalization of the instrumental
variables estimator of the CACE in the presence of noncompliers is given by:
τˆCACE =
E (Yi11 − Yi10 | Si = 1)
P(Ti = Di = 1 | Si = 1) , (5)
which is equivalent to scaling the ITT effect by the sample proportion of treated compliers
(e.g., Freedman, 2006). Eq. (5) is identified under Assumptions (5) and (6).
4.1 Simulation design
The simulation is designed so that the effect of treatment is heterogeneous and depends on
covariates which are different in the RCT and target population. The design satisfies the
conditional independence assumptions in Figure 1.
In the simulation, RCT eligibility, complier status, and treatment assignment in the popu-
lation depend on multivariate normal covariates (W 1i ,W
2
i ,W
3
i ,W
4
i ) with means (0.5, 1,−1,−1)
and covariances Cov(W 1i ,W
2
i ) = Cov(W
1
i ,W
4
i ) = Cov(W
2
i ,W
4
i ) = Cov(W
3
i ,W
4
i ) = 1
and Cov(W 1i ,W
3
i ) = Cov(W
2
i ,W
3
i ) = 0.5. The first three covariates are observed by the
researcher and W 4i is unobserved. Ui, Vi, Ri, and Qi are standard normal error terms.
Ui, Vi, Ri, Qi, and (W
1
i ,W
2
i ,W
3
i ,W
4
i ) are mutually independent.
The equation for selection into the RCT is
Si = I(e2 + g1W 1i + g2W 2i + g3W 3i + e4W 4i +Ri > 0).
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The parameter e2 varies the fraction of the population eligible for the RCT and e4 varies the
degree of confounding with sample selection. We set the constants g1, g2, and g3 to be 0.5,
0.25, and 0.75, respectively.
Complier status is determined by
Ci = I(e3 + h2W 2i + h3W 3i + e5W 4i +Qi > 0),
where e3 varies the fraction of compliers in the population, and e5 varies the degree of
confounding with treatment assignment. We set the constants h2 and h3 to 0.5.
For individuals in the population (Si = 0), treatment is assigned by
Ti = I(e1 + f1W 1i + f2W 2i + e6W 4i + Vi > 0),
where e1 varies the fraction eligible for treatment in the population and e6 varies the degree
of confounding with sample selection. We set the constants f1 and f2 to 0.25 and 0.75,
respectively. For individuals in the RCT (S1 = 1), treatment assignment Ti is a sample from
a Bernoulli distribution with probability p = 0.5.
Finally, the response is determined by
Yisd = a+ bDi + c1W
1
i + c2W
2
i + c3W
4 + dUi,
where we set a, c1, c3, and d to 1 and c2 to 2. The treatment effect b is heterogeneous:
b =
 1, if W
1
i > 0.75
−1, if W 1i ≤ 0.75
We generate a population of 30,000 individuals and randomly sample 5,000. Those among
the 5,000 who are eligible for the RCT (Si = 1) are selected. Similarly, we sample 5,000
individuals from the population and select those who are not eligible for the RCT (Si = 0)
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to be our observational study participants.8 We set each individual’s treatment received Di
according to their treatment assignment and complier status and observe their responses
Yisd. In this design, the manner in which Si, Ti, Di, Ci, and Yisd are simulated ensures that
Assumptions (1) – (6) hold.
In the assigned-treatment RCT group (Si = 1, Ti = 1), we train a gradient boosting
algorithm on the covariates to predict who in the control group (Si = 1, Ti = 0) would comply
with treatment (Ci = 1), which is unobservable. These individuals would have complied
had they been assigned to the treatment group. For this group of observed compliers to
treatment and predicted compliers from the control group of the RCT, we estimate the
response surface using gradient boosting with features (W 1i ,W
2
i ,W
3
i ) and Di. The PATT-C
is estimated according to the estimation procedure outlined above.
4.2 Simulation results
We vary each of the parameters e1, e2, e3, e4, e5, and e6 along a grid of five random standard
normal values in order to generate different combinations of rates of compliance, treatment
eligibility, RCT eligibility in the population, and confounding. For each possible combina-
tion of the six parameters, and holding all other parameters constant, we compute over 10
simulation runs the average root mean squared error (RMSE) between the true population
average treatment effect and the PATT-C, PATT, or CACE estimates. Averaging across
combinations, the unadjusted population estimator yields the highest average RMSE (1.06),
followed by the CACE (0.89), and the PATT-C (0.76).
Figures 2 and A1 show the average RMSE of the estimators as a function of the population
compliance rate and the share of population members eligible to participate in the RCT or
the population treatment rate, respectively. The PATT estimator does not correct for bias
resulting from noncompliance in the population and consequently performs poorly when the
population compliance rate is relatively low (i.e., ≤ 60%). The PATT-C estimator corrects
8This set-up mimics the reality that a population census is usually impossible.
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for noncompliance in the population and thus outperforms the PATT in low-compliance
settings. The CACE corrects for noncompliance in the sample, and underperforms compared
to the PATT-C due to differences between the sample and population.
Figure 2: Average RMSE, binned by compliance rate and percent eligible for the RCT.
Darker tiles correspond to higher errors and white tiles correspond to missing simulated
data.
Figure 3 compares the average RMSE of the estimators at varying levels of compliance
in the population. The error for each of the estimators predictably decreases as a greater
share of population members comply with treatment. PATT-C outperforms both PATT and
CACE in terms of minimizing RMSE when the population compliance rate is below 90%.
The PATT outperforms the PATT-C only at nearly perfect population compliance (i.e., 90%
16
compliance rate), and the CACE outperforms the PATT when the population compliance
rate is at 60% or below.
Figures A2, A3, and A4 plot the relationships between estimation error and the degrees
of confounding in the mechanisms that determine compliance, treatment assignment, and
sample selection, respectively. The estimation error of PATT-C is comparatively less in-
variant to increases in the degree of confounding in the three mechanisms compared to its
unadjusted counterpart. The estimation error of CACE is generally more variable than that
of the population estimators due to CACE’s inability to account for differences between the
sample and target population.
Figure 3: Average RMSE according to compliance rates in the population.
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5 Application: Medicaid and health care use
We apply the proposed estimator to measure the effect of Medicaid coverage on health care
use for a target population of adults who may benefit from expansions to the Medicaid
program. In particular, we examine the population of nonelderly adults in the U.S. with
household incomes at or below 138% of the Federal Poverty Level (FPL) — which amounts
to $32,913 for a four–person household in 2014 — who may be eligible for Medicaid following
the Affordable Care Act (ACA) expansion.
We draw RCT data from the Oregon Health Insurance Experiment (OHIE) (Finkelstein
et al., 2012; Taubman et al., 2014), which randomly assigned Medicaid coverage to the
uninsured and examined their subsequent health care use. Subsequent research calls in to
question the external validity of the OHIE, which resulted in the counterintuitive finding
that Medicaid increased ER use among RCT participants. For example, quasi-experimental
studies on the impact of the 2006 Massachusetts health reform — which served as a model
for the ACA — show that ER use decreased or remained constant following the reform
(Miller, 2012; Kolstad and Kowalski, 2012). A challenge to the external validity of the OHIE
is that it’s exclusion criteria was likely more restrictive than government health insurance
expansions.
5.1 RCT sample
In 2008, a group of uninsured low-income adults participated in the OHIE for the chance to
apply to receive health insurance through a state Medicaid program. In line with program
eligibility requirements, participants were restricted to Oregon residents aged 19 to 64 who
were not otherwise eligible for public insurance, who had been without insurance for six
months, had income below the FPL, and held assets below $2,000. Treatment assignment
occurred at the household level: participants selected by the lottery won the opportunity for
themselves and any household member to apply for Medicaid. Within a sample of 74,922
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individuals representing 66,385 households, 29,834 participants were selected by the lottery;
the remaining 45,008 participants served as controls in the experiment.
Participants in selected households were enrolled in Medicaid if they returned an enroll-
ment application within 45 days of receipt. Only 30% of participants in selected households
successfully enrolled. The low compliance rate is primarily due to failure to return an ap-
plication or demonstrate income below the FPL. Compliance is measured using a binary
variable indicating whether the participant was enrolled in any Medicaid program during
the study period.
We include as covariates in our response and complier models (S.1 and S.3, respectively)
pretreatment information on participant age, race, gender, education, marital status, num-
ber of children in the household, employment status, health status, and household income.
We also include indicator variables on household size because lottery selection was random
conditional on the number of household members. All analyses in the current application
cluster-adjust standard errors at the household level because treatment occurs at the house-
hold level. The analyses also use survey weights to adjust for the probability of being sampled
and non-response.
The response data originate from a mail survey containing questions about health insur-
ance and health care use. The response variables measure health care use in terms of the
number of ER and primary care (i.e., outpatient) visits in the past six months. Following
Finkelstein et al. (2012), indicator variables for survey wave and interactions with household
size indicators are also included as predictors in the response and complier models because
the proportion of treated participants varies across the survey waves.
5.2 Observational data
We acquire data on the target population from the National Health Interview Study (NHIS)
for years 2008 to 2017.9 We restrict the sample to respondents with income below 138%
9A possible limitation of this application is that it ignores the complex sampling techniques of the NHIS
sample design such as differential sampling, which is discussed in detail in Parsons et al. (2014).
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of the FPL and who are uninsured or on Medicaid and select covariates on respondent
characteristics that match the OHIE pretreatment covariates. We use a recoded variable
that indicates whether respondents are on Medicaid as an analogue to the OHIE compliance
measure. The outcomes of interest from the NHIS are based on questions that are virtually
identical to the OHIE mail survey questions, except that the utilization questions in the
NHIS are asked with a 12 month rather than a 6 month look-back period.10
5.3 Verifying assumptions
In order for τPATT-C to be identified, Assumptions (1) – (6) must be met. Assumption (1)
ensures that potential outcomes for participants in the target population would be identical
to their outcomes in the RCT if they had been randomly assigned their observed treatment.
In the empirical application, Medicaid coverage for uninsured individuals was applied in the
same manner in the RCT as it is in the population. Differences in potential outcomes due
to sample selection might arise, however, if there are differences in the mail surveys used to
elicit health care use responses between the RCT and the nonrandomized study.
We cannot directly test Assumptions (3) and (4), which state that potential outcomes for
treatment and control are independent of sample assignment for individuals with the same
covariates and assignment to treatment. The assumptions are only met if every possible
confounder associated with the response and the sample assignment is accounted for. In
estimating the response surface, we use all demographic, socioeconomic, and pre-existing
health condition data that were common in the OHIE and NHIS data. Potentially important
unobserved confounders include the number of hospital and outpatient visits in the previous
year, proximity to health services, and enrollment in other federal programs.
The final two columns of Table A1 compares RCT participants selected for Medicaid
with population members on Medicaid. Compared to the RCT compliers, the population
members who received treatment are younger, female, and more racially and ethnically
10Following Finkelstein et al. (2012), we resolve this discrepancy by halving the NHIS responses in order
to make them comparable to the OHIE outcomes.
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diverse. Diagnoses of diabetes, asthma, high blood pressure, and heart disease are more
common among the population on Medicaid then the RCT treated.
Strong ignorability assumptions may also be violated due to the fact that the OHIE
applied a more stringent exclusion criteria compared to the NHIS sample. While the RCT
and population sample both screened for individuals below the FPL, only the RCT required
those enrolled to recertify their household income eligibility during the study period. Strong
ignorability would not hold if the failure to recertify is correlated with unobserved variables.
Following Assumption (5), we assume no interference between households in the OHIE
because treatment assignment occured at the household level. Within-household interference
is not possible in this RCT because household members share the same treatment status.
Interference between households would threaten the no-interference assumption in the un-
likely case that the Medicaid coverage of individuals in treated households affects the health
care use of individuals in households assigned to control.
Assumption (2) is violated if assignment to treatment influences the compliance status
of individuals with the same covariates. The compliance ensemble can accurately classify
compliance status for 78% of treated RCT participants with only the number of household
members, survey wave (and the interaction between these indicators and household size
indicators), and pretreatment covariates — and not treatment assignment — as predictors
.11 This gives evidence in favor of the conditional independence assumption.
The exclusion restriction assumption ensures treatment assignment affects the response
only through enrollment in Medicaid. It is reasonable that a person’s enrollment in Medicaid,
not just their eligibility to enroll, would affect their hospital use. For private health insurance
one might argue that eligibility may be be negatively correlated with hospital use, as people
with pre-existing conditions are less often eligible yet go to the hospital more frequently.
This should not be the case with a federally funded program such as Medicaid.
11The compliance ensemble is evaluated in terms of 10–fold cross–validated MSE. The distribution of
MSE for the ensemble and its candidate algorithms are provided in Table A2.
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5.3.1 Placebo tests
Similar to the procedure proposed by (Hartman et al., 2015), we conduct placebo tests to
check whether the average outcomes differ between the RCT compliers on Medicaid and
the adjusted population members who received Medicaid.12 If the placebo tests detect a
significant difference between the mean outcomes of these groups, it would indicate that
either Assumption (1) (for d = 1), or Assumptions (3) and (4) are violated.
Table A3 reports the results of placebo tests for the weighted difference-in-mean outcomes
of RCT compliers and adjusted population members who received treatment. The mean
outcome of RCT compliers is calculated from the observed RCT sample and is weighted by
OHIE survey weights. The adjusted population mean is the counterfactual Yi11 estimated
from S.4 of the estimation procedure, and weighted by NHIS survey weights.
Tests of equivalence between the two groups indicate that the differences across each
outcome are not statistically significant at the conventional level of significance (p ≤ 0.05).
These results imply that the PATT-C estimator is not biased by differences in how Medi-
caid is delivered or health outcomes are measured between the RCT and population, or by
differences in sample or population members’ unobserved characteristics.
5.3.2 Sensitivity to no defiers assumption
Angrist et al. (1996) show that the bias due to violations of Assumption (6) is equiva-
lent to the difference of average causal effects of treatment received for compliers and de-
fiers, multiplied by the relative proportion of defiers, P(i is a defier)/(P(i is a complier]) −
P(i is a defier)).
Table A4 reports the distribution of participants in the OHIE by status of treatment
assignment and treatment received. Assumption (6) does not hold due to the presence of
defiers; i.e., participants who were assigned to control and enrolled in Medicaid during the
12Note that a placebo test for Assumption (2) is not possible because we never observe whether RCT
controls would actually take-up treatment if assigned.
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study period. About 7% of the RCT sample were assigned to control but were enrolled in
Medicaid (Ti < Di) and 66% of the sample complied with treatment assignment (Di = Ti),
which results in a bias multiplier of 0.1. Suppose that the difference of average causal effects
of Medicaid received on ER use for compliers and defiers is 1.2%. The resulting bias is
only 0.1%, which would not meaningfully alter the interpretation of the PATT-C or CACE
estimates reported below.
5.4 Empirical results
We compare PATT-C, PATT, and CACE estimates for ER and outpatient use. We obtain
estimates for the overall group of participants and subgroups according to pretreatment char-
acteristics. Subgroup treatment effects are estimated by taking differences across response
surfaces for a given binary covariate, and response surfaces are estimated with the ensem-
ble mean predictions. We include binary indicators for treatment received, household size,
survey wave (and interactions), and pretreatment covariates as predictors in the response
models.
Table A5 compares population and sample estimates of the effect of Medicaid on health
care use. The PATT-C estimates indicate that Medicaid coverage has a statistically sig-
nificant and negative effect on the number of ER and outpatient visits. The population
treatment effect estimates are in a different direction and much smaller in size relative the
CACE estimates on the OHIE sample, which can be explained by differences in the covariate
distributions of the RCT sample and population members.
Figures A5 and A6 examine heterogeneous treatment effect estimates on ER and out-
patient use in the population. We find that decreases in ER use due to Medicaid coverage
are significantly larger for younger and female population members and those with two or
more children in the household. PATT-C estimates of the effect of Medicaid on the number
of outpatient visits is negative across all pretreatment covariates and are relatively substan-
tial for population members who are older, employed or self-employed, diagnosed with high
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blood pressure, and have household income of over $25, 000.
6 Discussion
The simulation results presented in Section 4 show that the PATT-C estimator outperforms
its unadjusted counterpart when the compliance rate is low. Of course, the simulation
results depend on the particular way we parameterized the compliance, selection, treatment
assignment, and response schedules.
In particular, the strength of correlation between the covariates and compliance governs
how well the estimator will perform, since S.1 of the estimation procedure is to predict who
would be a complier in the RCT control group, had they been assigned to treatment. If it is
difficult to predict compliance using the observed covariates, then the estimator will perform
badly because of noise introduced by incorrectly treating noncompliers as compliers. Further
research should be done into ways to test how well the model of compliance works in the
population or explore models to more accurately predict compliance in RCTs. Accurately
predicting compliance is not only essential for yielding unbiased estimates of the average
causal effects for target populations, it is also useful for researchers and policymakers to
know which groups of individuals are unlikely to comply with treatment.
In the OHIE trial, less than half of those selected to receive Medicaid benefits actu-
ally enrolled. The compliance ensemble accurately classified compliance status for 78% of
treated RCT participants using only the pretreatment covariates as features. While we don’t
know how well the compliance ensemble predicts for the control group, the control group
should be similar to the treatment group on pretreatment covariates because of the RCT
randomization. The model’s performance on the training set suggests that compliance is not
purely random and depends on observed covariates. This gives evidence in favor of using
the proposed estimator.
In the empirical application, the sample population differs in several dimensions from
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the target population of individuals who will be covered by other Medicaid expansions, such
as the ACA expansion to cover all adults up to 138% of the FPL. For instance, the RCT
participants are disproportionately white urban–dwellers (Taubman et al., 2014). The RCT
participants volunteered for the study and therefore may be in poorer health compared to
the target population. These differences in baseline covariates make reweighting or response
surface methods necessary to extend the RCT results to the population.
Explicitly modeling compliance allows us to decompose population estimates by subgroup
according to pretreatment covariates common to both RCT and observational datasets; e.g,
demographic variables, pre-existing conditions, and insurance coverage. We find substantial
differences between sample and population estimates in terms of race, education, and health
status subgroups. This pattern is expected because RCT participants volunteered for the
study and are predominately white and educated.
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Appendix
Figure A1: Average RMSE binned by compliance rate and treatment rate.
29
Figure A2: Average RMSE according to degree of confounding in compliance.
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Figure A3: Average RMSE according to degree of confounding in treatment assignment.
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Figure A4: Average RMSE according to degree of confounding in sample selection.
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Table A1: Pretreatment covariates and responses for OHIE and NHIS respondents by Med-
icaid coverage status.
OHIE OHIE NHIS
no Medicaid Medicaid Medicaid
n = 13, 573 n = 5, 547 n = 6, 256
Covariate N % N % N %
Age:
19-49 4,166 31.0 1,473 26.9 4,322 69.2
50-64 9,407 69.0 4,074 73.1 1,934 30.8
Cohabitation:
Living with partner or spouse 6,081 44.8 2,011 35.9 1,949 30.7
Education:
Less than high school 2,181 15.8 1,028 18.3 1,941 30.8
High school diploma or GED 6,948 50.9 2,948 52.7 2,074 33.3
Voc. training / 2-year degree 2,889 21.5 1,118 20.8 1,809 29.1
4-year college degree or more 1,555 11.8 453 8.2 432 6.8
Employment status:
Employed or self-employed 7,340 54.6 1,991 36.4 2,122 33.9
Ethnicity:
Asian 450 3.6 166 3.1 282 4.3
American Indian or Alaska Native 783 5.7 298 5.1 130 2.1
Black 193 3.1 247 3.5 1,723 27.0
Hispanic 1,242 9.3 509 9.0 1,570 24.9
White 11,453 84.2 4,675 84.7 3,899 63.0
Other 951 7.0 385 7.2 321 5.2
Gender:
Female 7,807 57.8 3,280 59.3 4,285 68.4
Health status:
Asthma 2,114 15.6 1,004 18.3 1,269 20.1
Diabetes 1,484 10.7 595 11.0 864 14.0
Ephysema or Chronic Bronchitis 889 6.3 471 8.6 394 6.2
Heart condition 302 2.1 178 3.1 529 8.5
High blood pressure 3,740 27.4 1,533 28.1 2,162 34.9
Income:
< $10k 6,003 43.7 3,488 62.6 2,587 41.8
$10k-$25k 5,583 41.7 1,678 30.5 3,095 49.2
> $25k 1,987 14.6 381 6.9 574 9.0
No. children in household:
0 8,270 61.1 3,120 56.4 2,958 47.3
1-2 3,926 28.8 1,762 32.2 2,327 37.4
> 2 1,377 10.1 665 11.4 971 15.3
Responses Mean S.d. Mean S.d. Mean S.d.
# ER visits 0.45 1.00 0.40 0.85 0.25 0.54
# outpatient visits 1.98 2.97 1.98 2.92 1.07 1.21
Notes: percentages calculated using OHIE or NHIS survey weights.
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Table A2: Distribution of MSE for compliance ensemble.
Algorithm Mean SE Min. Max.
Super learner (SuperLearner) 0.22 0.001 0.21 0.23
Lasso regression (glmnet) 0.22 0.001 0.21 0.23
Random forests (randomForest) 0.27 0.002 0.25 0.29
Ridge regression (glmnet) 0.22 0.001 0.21 0.23
Notes: MSE is 10-fold cross-validated error for super learner ensemble and candidate algorithms. R
package used for implementing each algorithm in parentheses.
Table A3: Placebo test: difference-in-mean outcomes of RCT compliers and adjusted popu-
lation members who received treatment.
Outcome RCT complier Adjusted population Difference p-value
mean mean
# ER vists 0.44 0.46 -0.02 0.22
# outpatient visits 1.96 2.02 -0.06 0.08
Notes: p-values corresponding to survey-weighted difference-in-means estimated from cluster-adjusted
bootstrapped standard errors.
Table A4: Distribution of OHIE participants by status of treatment assignment (Ti) and
treatment received (Di).
Di = 0 Di = 1 n
Ti = 0 8,343 1,265 9,608
Ti = 1 5,230 4,282 9,512
n 13,573 5,547 19,120
Table A5: Comparison of population and sample estimates.
Estimator
Outcome
# ER visits # outpatient visits
PATT-C -0.002 [-0.003, -0.001] -0.017 [-0.019, -0.015]
PATT -0.001 [-0.002, -0.001] 0.003 [-0.002, 0.008]
CACE 0.023 [-0.039, 0.086] 0.225 [0.042, 0.408]
Notes: survey-weighted difference-in-means and corresponding 95% bootstrap confidence intervals
estimated from cluster-adjusted bootstrapped standard errors.
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Figure A5: Heterogeneity in population treatment effect estimates: # ER visits. Notes:
Horizontal lines represent 95% bootstrap confidence intervals estimated from cluster-adjusted
bootstrapped standard errors.
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Figure A6: Heterogeneity in population treatment effect estimates: # outpatient visits. See
notes to Fig. A5.
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Table A6: Error and weights for candidate algorithms in response ensemble for RCT com-
pliers.
# ER visits
Algorithm MSE Weight
Additive regression, degree = 2 (gam) 0.81 0
Additive regression, degree = 3 (gam) 0.81 0
Additive regression, degree = 4 (gam) 0.81 0
Boosted regression (gbm) 0.79 0
Lasso regression (glmnet) 0.79 0.76
Random forests, #preds. = 1 (randomForest) 0.79 0.18
Random forests, #preds. = 10 (randomForest) 0.83 0.06
Regularized linear regression, α = 0.25 (glmnet) 0.79 0
Regularized linear regression, α = 0.5 (glmnet) 0.79 0
Regularized linear regression, α = 0.75 (glmnet) 0.79 0
Ridge regression (glmnet) 0.79 0
# outpatient visits
Algorithm MSE Weight
Additive regression, degree = 2 (gam) 6.60 0
Additive regression, degree = 3 (gam) 6.60 0
Additive regression, degree = 4 (gam) 6.60 0
Boosted regression (gbm) 6.48 0
Lasso regression (glmnet) 6.47 0.87
Random forests, #preds. = 1 (randomForest) 6.47 0
Random forests, #preds. = 10 (randomForest) 6.73 0.13
Regularized linear regression, α = 0.25 (glmnet) 6.47 0
Regularized linear regression, α = 0.5 (glmnet) 6.47 0
Regularized linear regression, α = 0.75 (glmnet) 6.47 0
Ridge regression (glmnet) 6.47 0
Notes: cross-validated error and weights used for each algorithm in super learner ensemble. MSE is
the ten-fold cross-validated mean squared error for each algorithm. Weight is the coefficient for the Super
Learner, which is estimated using non-negative least squares based on the Lawson-Hanson algorithm. R
package used for implementing each algorithm in parentheses. #preds. is the number of predictors randomly
sampled as candidates in each decision tree in random forests algorithm. α is a parameter that mixes L1
and L2 norms. degree is the smoothing term for smoothing splines.
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Table A7: Error and weights for candidate algorithms in response ensemble for all RCT
participants.
# ER visits
Algorithm MSE Weight
Additive regression, degree = 2 (gam) 0.76 0
Additive regression, degree = 3 (gam) 0.76 0
Additive regression, degree = 4 (gam) 0.76 0
Boosted regression (gbm) 0.75 0
Lasso regression (glmnet) 0.75 0
Random forests, #preds. = 1 (randomForest) 0.75 1
Random forests, #preds. = 10 (randomForest) 0.79 0
Regularized linear regression, α = 0.25 (glmnet) 0.75 0
Regularized linear regression, α = 0.5 (glmnet) 0.75 0
Regularized linear regression, α = 0.75 (glmnet) 0.75 0
Ridge regression (glmnet) 0.75 0
# outpatient visits
Algorithm MSE Weight
Additive regression, degree = 2 (gam) 6.44 0
Additive regression, degree = 3 (gam) 6.44 0
Additive regression, degree = 4 (gam) 6.44 0
Boosted regression (gbm) 6.39 0
Lasso regression (glmnet) 6.39 0.87
Random forests, #preds. = 1 (randomForest) 6.39 0
Random forests, #preds. = 10 (randomForest) 6.61 0.13
Regularized linear regression, α = 0.25 (glmnet) 6.39 0
Regularized linear regression, α = 0.5 (glmnet) 6.39 0
Regularized linear regression, α = 0.75 (glmnet) 6.39 0
Ridge regression (glmnet) 6.39 0
See notes to Fig. A6.
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